Rt-Pcr Sar-Cov Test

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-100g 100 µg
EUR 1525

Human IgG antibody Laboratories manufactures the rt-pcr sar-cov test reagents distributed by Genprice. The Rt-Pcr Sar-Cov Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Rt-Pcr products are available in stock. Specificity: Rt-Pcr Category: Sar-Cov Group: Test

Human IgG Quick test strip

10Tests
EUR 260

Human IgG Quick test strip

5x10Tests
EUR 1180

Rhinovinis.Enterovirus Real-Time PCR Test

96
EUR 5750

Mikrogen Diagnostik recomLine SARS-CoV-2 IgG Lateral Strip Test Kit

20 Tests
EUR 880

Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

100 µl
EUR 650

Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

1 ml
EUR 7200

Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

200 µl
EUR 2100

Test information

Chikungunya Vines Real-Time PCR Test

P0066 96
EUR 5500

SARS CoV-2 One-Step PCR kit

Oneq-H731-100R 100T
EUR 1932

SARS CoV-2 One-Step PCR kit

Oneq-H731-150R 150T
EUR 2646

SARS CoV-2 One-Step PCR kit

Oneq-H731-50R 50T
EUR 1410

Micro test tubes 3810X PCR clean - PK1000

E0030125215 PK1000
EUR 55.35

Vv"estNile Vinis Real-Time PCR Test

P0148 96
EUR 5550

Influenza A'B & RSV Real-Time PCR Test

P0187 96
EUR 5700

Bac Multi-Screen Real-TM NEW RT PCR test for detection of opportunistic infections

R1-P028-12- 12
EUR 850.2

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-100g 100 µg
EUR 850

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-20g 20 µg
EUR 100

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-50g 50 µg
EUR 450

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 1T
EUR 9.6
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-25 25T/kit
EUR 42
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

SARS-CoV-2 Antigen Rapid Test Kit

GF101A2 25 Test/kit Ask for price

Influenza A Typing Real-Time PCR Test

P0188 96
EUR 5800

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-100g 100 µg
EUR 1525